Should I induce vomiting after a patient has ingested albuterol (salbutamol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should You Induce Vomiting After Albuterol Ingestion?

Do not induce vomiting after albuterol (salbutamol) ingestion—this intervention is not indicated and may cause harm without providing benefit. 1

Why Vomiting Induction Is Not Recommended

The route of albuterol administration is critical to understanding this recommendation:

  • Albuterol is administered via inhalation (nebulizer or metered-dose inhaler), not orally, which means it bypasses the gastrointestinal tract entirely and is absorbed directly through the respiratory mucosa 1
  • For therapeutic use in acute bronchospasm, there are no contraindications related to recent vomiting because the drug never enters the GI system 1
  • If vomiting has already occurred naturally, you can still safely administer inhaled albuterol without delay, as bronchospasm treatment is time-sensitive 1, 2

Management of Accidental Oral Ingestion

If the question pertains to accidental oral ingestion of albuterol tablets or syrup (a different scenario), the evidence still argues against inducing vomiting:

Toxicity Threshold and Clinical Course

  • The threshold dose for significant toxicity is 1 mg/kg or higher, with most children experiencing only benign, self-limited symptoms 3
  • For ingestions ≤0.6 mg/kg, home observation without intervention is sufficient 4
  • For ingestions >0.6 mg/kg, direct medical evaluation and gastrointestinal decontamination should be considered, but this refers to activated charcoal administration in the emergency department, not ipecac-induced vomiting 4

Expected Clinical Effects

Common findings after oral albuterol overdose include 3, 5:

  • Tachycardia (57% of cases)
  • Widened pulse pressure (50%)
  • Agitation or restlessness (45%)
  • Tremor
  • Hypokalemia (26%)
  • Hyperglycemia (50%)

These effects are typically transient and resolve within 4-6 hours without specific treatment 4, 3, 6

Why Ipecac Is Contraindicated

In the retrospective study of 95 pediatric albuterol ingestions, only 12 patients received ipecac at home, and no serious events occurred in the entire series regardless of whether ipecac was given 4. Modern toxicology guidelines have largely abandoned ipecac-induced emesis because:

  • It delays administration of activated charcoal (the preferred decontamination method)
  • It provides minimal benefit for drug removal
  • It can cause protracted vomiting that complicates clinical assessment

Appropriate Management Algorithm

For therapeutic inhaled albuterol use:

  • Administer albuterol via nebulizer or MDI regardless of recent vomiting 1
  • Use standard dosing: 2.5-5 mg every 20 minutes for 3 doses initially in adults 1

For accidental oral ingestion:

  • If ≤0.6 mg/kg: Observe at home 4
  • If >0.6 mg/kg: Seek emergency department evaluation for possible activated charcoal administration (not ipecac) 4
  • Monitor for tachycardia, tremor, and agitation 3
  • Expect resolution within 6 hours in 72% of cases 3
  • Watch for late hypoglycemia (4+ hours post-ingestion) as a rare complication 6

Critical Pitfall to Avoid

Do not delay inhaled albuterol administration in a patient with bronchospasm while assessing vomiting history—the inhaled route bypasses the GI tract entirely, and bronchospasm treatment is time-sensitive 1, 2. The most common cause of death in severe asthma is asphyxia, not medication side effects 7.

References

Guideline

Administration of Albuterol in Patients Who Have Vomited

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Persistent Wheezing After Albuterol Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Unintentional albuterol ingestion in children.

Pediatric emergency care, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.